Targeting pro-inflammatory cytokines and chemokine as potential novel strategy in adjuvant development for anti- hcv therapy
Hepatitis C virus (HCV) is the main cause of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC) worldwide. The risk for the development of HCC increases with the severity of liver inflammation and fibrosis. Inflammatory cytokines are critical components of the immune system and infl...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Scientific Publishers
2018
|
| Subjects: |